The invention comprises a method and apparatus for holding a Cannabis product, such as a beverage container having a resealable closure that remains affixed to the beverage container when in both an open position and a closed position, where a cavity within the container comprises at least two servings of tetrahydrocannabinol (THC). The resealable closure optionally includes a slideable/rotatable element that is slideable/rotatable along a horizontal plane relative to an upper surface of the beverage container, the slideable/rotatable closure element alternatingly closing an opening in the lid when in a first position and allowing access through the opening when in a second position. The resealable container in combination with graphical THC serving size indicators allows a consumer to consume a known amount of THC.

The invention comprises an apparatus, comprising: (1) a dissolvable tablet, comprising: a support matrix, the support matrix comprising at least two percent by mass a gassing agent, the gassing agent comprising at least one of: a carbonic acid, H.sub.2CO.sub.3; a bicarbonate, HCO.sub.3; a bicarbonate salt; a carbonate, CO.sub.3.sup.2−; and a carbonate salt; and (2) at least one milligram of tetrahydrocannabinol, where the dissolvable tablet optionally includes an acid and a buffer at least partially separating the gassing agent and the acid, where the tetrahydrocannabinol is blended into the support matrix of the dissolvable tablet prior to formation of the dissolvable tablet and/or is infused into a pre-made tablet comprising the support matrix.

The invention comprises an apparatus, comprising: (1) a dissolvable tablet, comprising: a support matrix, the support matrix comprising at least two percent by mass a gassing agent, the gassing agent comprising at least one of: a carbonic acid, H.sub.2CO.sub.3; a bicarbonate, HCO.sub.3; a bicarbonate salt; a carbonate, CO.sub.3.sup.2−; and a carbonate salt; and (2) at least one milligram of tetrahydrocannabinol, where the dissolvable tablet optionally includes an acid and a buffer at least partially separating the gassing agent and the acid, where the tetrahydrocannabinol is blended into the support matrix of the dissolvable tablet prior to formation of the dissolvable tablet and/or is infused into a pre-made tablet comprising the support matrix.

The invention provides novel regimens for treatment of neurodegenerative disorders utilising methylthioninium (MT)-containing compounds. The regimens are based on novel findings in relation to the dosage of MT compounds, and their interaction with symptomatic treatments based on modulation of acetylcholinesterase levels.

The invention provides novel regimens for treatment of neurodegenerative disorders utilising methylthioninium (MT)-containing compounds. The regimens are based on novel findings in relation to the dosage of MT compounds, and their interaction with symptomatic treatments based on modulation of acetylcholinesterase levels.

The present invention pertains to a Lonicera Japonica flower water extract composition for preventing or treating Helicobacter pylori infection, the composition containing secoxyloganin as an active ingredient. The extract contains a specific amount of secoxyloganin, and thus exhibited excellent antibacterial effects when used on Helicobacter pylori bacteria, and exhibited excellent effects in terms of reducing Helicobacter pylori IgG antibody expression in the blood, alleviating histopathological lesions, and reducing cytokine expression when used on Helicobacter pylori-infected mice. Thus, the Lonicera Japonica flower water extract of the present invention can be usefully used as a composition for preventing or treating Helicobacter pylori infection.

The present invention pertains to a Lonicera Japonica flower water extract composition for preventing or treating Helicobacter pylori infection, the composition containing secoxyloganin as an active ingredient. The extract contains a specific amount of secoxyloganin, and thus exhibited excellent antibacterial effects when used on Helicobacter pylori bacteria, and exhibited excellent effects in terms of reducing Helicobacter pylori IgG antibody expression in the blood, alleviating histopathological lesions, and reducing cytokine expression when used on Helicobacter pylori-infected mice. Thus, the Lonicera Japonica flower water extract of the present invention can be usefully used as a composition for preventing or treating Helicobacter pylori infection.

An encapsulation method is disclosed for the capture of natural flavors within a clean-label derived from a malt comprising at least partially germinated whole grain seed, pulses, legumes, false grains or flour derived therefrom.

An encapsulation method is disclosed for the capture of natural flavors within a clean-label derived from a malt comprising at least partially germinated whole grain seed, pulses, legumes, false grains or flour derived therefrom.

Provided is a solid milk containing suitable free fat and having strength adequate to resist breakage during handling. The solid milk is a solid milk having a solid form obtained by compression molding a powdered milk, in which a hardening index I.sub.F represented by the following Formula (1) when the solid milk is divided into a plurality of pieces (N pieces) in a height direction is 0.477 mm.sup.2 or more, Formula (1) being represented by a width w in a target region n, a thickness δ in the target region n, a specific surface area voxel ratio Sv.sub.voxel_n in the target region n, a content R.sub.0 of a total milk sugar, and a total crystal amount R.sub.n of a milk sugar in the target region n, and a content ratio FF of free fat in the solid milk is 1.23% by weight or less.

[00001]$\left[\mathrm{Math}.8\right]$$\begin{array}{cc}{I}_F={.Math.}_{n=1}^N\frac{w.Math.\delta }{{\left\{S_{V\mathrm{voxel}\_n}.Math.\left(R_0-R_n\right)\right\}}^2}\left[{\mathrm{mm}}^2\right]& \left(1\right)\end{array}$